NCT03346967View on ClinicalTrials.gov

Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

March 30, 2020

Conditions
Hormone Deficiency
Interventions
COMBINATION_PRODUCT

adipose-derived mesenchymal stem cells

Collect adipose-derived mesenchymal stem cells from the patients. Adipose-derived mesenchymal stem cells will be isolated, expanded and characterized in vitro under the GMP- grade procedure

Trial Locations (1)

10000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

All Listed Sponsors
lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT03346967 - Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency | Biotech Hunter | Biotech Hunter